Main navigation

The International Collaboration in Asthma, Allergy and Immunology (iCAALL)

Hundreds of millions of people in the world suffer from allergies, and it is estimated that 300 million have asthma*. Inadequate or improper diagnosis and treatment of these chronic diseases and of immunodeficiency disorders results in lost productivity and substantial medical and socioeconomic burdens throughout the world.

Recognizing a lack of consensus-driven information and general recommendations, four of the most influential allergy/immunology professional organizations have joined forces to launch the International Collaboration in Asthma, Allergy and Immunology (iCAALL). Participating in iCAALL are the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma & Immunology (ACAAI), the European Academy of Allergy and Clinical Immunology (EAACI) and the World Allergy Organization (WAO).

iCAALL is designed to collect and disseminate consensus-driven information about allergies, asthma and immunological diseases. Communicating this knowledge can positively impact diagnosis and treatment, as well as cost containment and policy decisions.

A major focus of this initiative is the production of a series of International Consensus (ICON) reports. These documents offer general recommendations based on global challenges in caring for patients with allergic and immunologic diseases. A Food Allergy ICON was published in April, 2012. An ICON on Pediatric Asthma was published in June, 2012.